ethylene oxide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Li, J; Li, W; Liu, S; Xiong, M; Yao, Y; Zhang, Q; Zhao, J; Zhong, C | 1 |
1 other study(ies) available for ethylene oxide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Nanoblock-mediated selective oncolytic polypeptide therapy for triple-negative breast cancer.
Topics: Animals; Cell Line, Tumor; Ethylene Oxide; Humans; Mice; Nanoparticles; Peptides; Polymers; Triple Negative Breast Neoplasms | 2023 |